about
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.Longitudinal medication usage in Alzheimer disease patients.Tools for multiple granularity analysis of brain MRI data for individualized image analysisLongitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials.Seizures in Alzheimer disease: who, when, and how common?MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths.Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer's diseaseChange in body mass index before and after Alzheimer's disease onset.Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging.Hearing loss and dementia - who is listening?Functional MRI detection of pharmacologically induced memory impairment.Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants.Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease.DTI analyses and clinical applications in Alzheimer's disease.Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume lossCognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study.Reliability and reproducibility of perfusion MRI in cognitively normal subjects.Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive studyDelusions and hallucinations are associated with worse outcome in Alzheimer diseaseDisruptive behavior as a predictor in Alzheimer diseaseAmygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.Correlates of objective and subjective measures of caregiver burden among dementia caregivers: influence of unmet patient and caregiver dementia-related care needsAtlas-based diffusion tensor imaging correlates of executive functionMulti-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's diseaseClinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the communityPutting names to faces: successful encoding of associative memories activates the anterior hippocampal formationDiabetes in midlife and cognitive change over 20 years: a cohort study.The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging.Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's diseaseAssociation of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.Incidence and predictors of seizures in patients with Alzheimer's disease.
P50
Q24647259-7A158817-C93F-46EE-977B-2FE68E10CECAQ30303063-A8220B24-F181-471A-AE51-0D6C10BC4740Q30549920-E2F512EC-AE31-41D4-A206-23BAA0028C2DQ30834257-2DCA40E2-3930-4687-BB1C-518272029B65Q31049335-353A7F5B-93FE-4024-BE6D-11522D4087D9Q33157686-9765051D-FB84-445F-9225-7DBFE1A5BE57Q33411170-181D7660-4801-43D4-A997-DC61C71E9673Q33546395-371707C9-98C6-47CC-B285-1DFF182276B9Q33632560-C53AB0C9-2310-467D-BD31-F272FB278A2BQ33665842-3AFA8873-3D20-41F9-978F-30EDBF57A4ECQ33802914-CC3BA48E-583E-4F86-9D0D-CF9F08739072Q33821172-3030F5E7-C23B-4A13-8AFC-C65DD22884D8Q33898082-5FA4C924-7570-40FC-A31C-AEEC1F10F7D1Q33914026-B6CEA3AD-0B5B-488E-A2E1-6DE9CD256247Q33947426-18AE6F9D-D703-4226-8B4F-C60541BF377AQ34039979-D09707CC-E9D4-4D40-AFE6-19D704B48B09Q34106300-5F7B2BE3-4924-4268-9605-520954F869E4Q34180413-FB8035A4-0532-4F78-AD3F-5DCB7BD99FBEQ34183841-FA217B6B-E1B0-417C-906B-B990558DA1B5Q34238449-796B6B09-AAD8-4507-B500-7E33D7D92A0FQ34480526-EEDFBFB7-7074-4DED-A622-3034E93DC296Q34528084-F436F1E9-7DAB-4B87-B385-DCE130001E3DQ34585956-5745BF9D-BA67-4C9C-A012-885CB02D56BFQ34738569-C774008A-F903-442C-BD85-283BB6C36BB5Q34786018-86941486-2082-470A-9444-05B4DDECB094Q34815785-11DBA6DD-503E-4C26-B43B-7080F72AD1C3Q35100330-C3E8F9FD-6B79-4897-8ED3-B7DAF550CC52Q35178541-CE0F3F7C-9186-4F8F-9F0A-09FA8E607035Q35588248-34909CEB-5BC2-497B-8D1A-788FAFE7B544Q35593109-4DEF0245-D88F-41AC-8739-22762E56E902Q35608514-4D3E9283-D670-43D4-ACE1-D289860B6E1DQ35667221-B64754E2-BBED-46B5-BC36-9B594D9302C8Q35772524-C6759558-84E0-4464-93BB-64035769B4D3Q35833686-F00256FF-97AF-4D15-9783-CA4CDDA252C9Q35844926-32D39590-A0B5-4F0A-A3A2-4D0381374921Q35846251-170D058B-A430-4347-BD86-E315553E5F43Q36149981-CF8ADDC3-453E-4B45-A8CD-9EA124F8A29CQ36240571-5CC63805-F1A3-4FF0-B67E-0BE4A1217228Q36276506-FF521E35-0C40-4E8C-B0C5-B80BA1FC5A11Q36474116-D0EC2B3C-A737-47ED-B522-FBDF4F898B97
P50
name
Marilyn Albert
@ast
Marilyn Albert
@en
Marilyn Albert
@nl
type
label
Marilyn Albert
@ast
Marilyn Albert
@en
Marilyn Albert
@nl
prefLabel
Marilyn Albert
@ast
Marilyn Albert
@en
Marilyn Albert
@nl